XNAS · Healthcare · Medical Devices
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | Q1 2026 | -1.00 | -2.09 | -109.00% | $2.4M | ❌ Miss | +3.85% | -5.07% | — |
| 2026-03-10 | Q4 2025 | -1.56 | -1.50 | +3.85% | $2.4M | ✅ Beat | +0.78% | -16.92% | -16.92% |
| 2025-11-12 |
| Q3 2025 |
| — |
| 0.56 |
| — |
| $2.2M |
| — |
| — |
| — |
| — |
| 2025-08-14 | Q2 2025 | -0.45 | -60.99 | -13453.33% | $1.7M | ❌ Miss | +0.91% | -6.21% | -25.89% |
| 2025-03-11 | Q4 2024 | -0.43 | -0.71 | -65.12% | $2.3M | ❌ Miss | -2.48% | -8.26% | -22.48% |
| 2024-11-11 | Q3 2024 | -1.28 | -1.13 | +11.72% | $2.4M | ✅ Beat | -5.85% | -34.15% | -36.59% |
| 2024-08-13 | Q2 2024 | -8.24 | -4.68 | +43.20% | $2.2M | ✅ Beat | +6.07% | -9.81% | -33.64% |
| 2024-05-07 | Q1 2024 | -32.55 | -21.00 | +35.48% | $1.9M | ✅ Beat | -1.29% | -12.53% | -16.10% |
Showing last 8 quarters.